{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T13:15:37Z","timestamp":1790774137467,"version":"4.1.0"},"reference-count":91,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,12,4]],"date-time":"2017-12-04T00:00:00Z","timestamp":1512345600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AAPS J"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1208\/s12248-017-0164-7","type":"journal-article","created":{"date-parts":[[2017,12,4]],"date-time":"2017-12-04T16:02:14Z","timestamp":1512403334000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":56,"title":["The Na+\/Cl\u2212-Coupled, Broad-Specific, Amino Acid Transporter SLC6A14 (ATB0,+): Emerging Roles in Multiple Diseases and Therapeutic Potential for Treatment and Diagnosis"],"prefix":"10.1208","volume":"20","author":[{"given":"Mohd Omar F.","family":"Sikder","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengping","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vadivel","family":"Ganapathy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6927-075X","authenticated-orcid":false,"given":"Yangzom D.","family":"Bhutia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,12,4]]},"reference":[{"key":"164_CR1","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1152\/physrev.1990.70.1.43","volume":"70","author":"HN Christensen","year":"1990","unstructured":"Christensen HN. Role of amino acid transport and countertransport in nutrition and metabolism. Physiol Rev. 1990;70:43\u201377.","journal-title":"Physiol Rev"},{"key":"164_CR2","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1242\/jeb.196.1.51","volume":"196","author":"HN Christensen","year":"1994","unstructured":"Christensen HN, Albritton LM, Kakuda DK, MacLeod CL. Gene-product designations for amino acid transporters. J Exp Biol. 1994;196:51\u20137.","journal-title":"J Exp Biol"},{"key":"164_CR3","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/s00424-003-1192-y","volume":"447","author":"MA Hediger","year":"2004","unstructured":"Hediger MA, Romero MF, Peng JB, Rolfs A, Takanaga H, Bruford EA. The ABCs of solute carriers: physiological, pathological and therapeutic implications of human membrane transport proteins. Pflugers Arch. 2004;447:465\u20138.","journal-title":"Pflugers Arch"},{"key":"164_CR4","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.tips.2016.11.008","volume":"38","author":"E Perland","year":"2017","unstructured":"Perland E, Frederiksson R. Classification systems of secondary active transporters. Trends Pharmacol Sci. 2017;38:305\u201315.","journal-title":"Trends Pharmacol Sci"},{"key":"164_CR5","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1039\/C6MD00005C","volume":"7","author":"C Colas","year":"2016","unstructured":"Colas C, Ung PM, Schlessinger A. SLC transporters: structure, function, and drug discovery. Medchemcomm. 2016;7:1069\u201381.","journal-title":"Medchemcomm"},{"key":"164_CR6","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1152\/physrev.00018.2006","volume":"88","author":"S Broer","year":"2008","unstructured":"Broer S. Amino acid transport across mammalian intestinal and renal epithelia. Physiol Rev. 2008;88:249\u201386.","journal-title":"Physiol Rev"},{"key":"164_CR7","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1042\/BCJ20160822","volume":"474","author":"S Broer","year":"2017","unstructured":"Broer S, Broer A. Amino acid homeostasis and signalling in mammalian cells and organisms. Biochem J. 2017;474:1935\u201363.","journal-title":"Biochem J"},{"key":"164_CR8","doi-asserted-by":"crossref","unstructured":"Bhutia YD, Ganapathy V. Protein digestion and absorption. In: Johnson LR, editor. Physiology of the gastrointestinal tract. 6th edition, in Press ed: Elsevier; 2017.","DOI":"10.1016\/B978-0-12-809954-4.00047-5"},{"key":"164_CR9","first-page":"2531","volume":"2016","author":"YD Bhutia","year":"1863","unstructured":"Bhutia YD, Ganapathy V. Glutamine transporters in mammalian cells and their functions in physiology and cancer. Biochim Biophys Acta. 1863;2016:2531\u20139.","journal-title":"Biochim Biophys Acta"},{"key":"164_CR10","doi-asserted-by":"crossref","first-page":"61","DOI":"10.3389\/fchem.2014.00061","volume":"2","author":"L Pochini","year":"2014","unstructured":"Pochini L, Scalise M, Galluccio M, Indiveri C. Membrane transporters for the special amino acid glutamine: structure\/function relationships and relevance to human health. Front Chem. 2014;2:61.","journal-title":"Front Chem"},{"key":"164_CR11","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1158\/0008-5472.CAN-09-3556","volume":"70","author":"CV Dang","year":"2010","unstructured":"Dang CV. Rethinking the Warburg effect with Myc micromanaging glutamine metabolism. Cancer Res. 2010;70:859\u201362.","journal-title":"Cancer Res"},{"key":"164_CR12","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.tibs.2010.05.003","volume":"35","author":"DR Wise","year":"2010","unstructured":"Wise DR, Thompson CB. Glutamine addiction: a new therapeutic target in cancer. Trends Biochem Sci. 2010;35:427\u201333.","journal-title":"Trends Biochem Sci"},{"key":"164_CR13","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.semcdb.2012.02.002","volume":"23","author":"D Daye","year":"2012","unstructured":"Daye D, Wallen KE. Metabolic reprogramming in cancer: unraveling the role of glutamine in tumorogenesis. Semin Cell Dev Biol. 2012;23:362\u20139.","journal-title":"Semin Cell Dev Biol"},{"key":"164_CR14","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.ccr.2012.02.014","volume":"21","author":"PS Ward","year":"2012","unstructured":"Ward PS, Thompson CB. Metabolic reprograming: a cancer hallmark even Warburg did not anticipate. Cancer Cell. 2012;21:297\u2013308.","journal-title":"Cancer Cell"},{"key":"164_CR15","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1038\/ncb2763","volume":"15","author":"CC Dibble","year":"2013","unstructured":"Dibble CC, Manning BD. Signal integration by mTORC1 coordinates nutrient input with biosynthetic output. Nat Cell Biol. 2013;15:555\u201364.","journal-title":"Nat Cell Biol"},{"key":"164_CR16","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.cmet.2016.03.013","volume":"23","author":"DCI Goberdhan","year":"2016","unstructured":"Goberdhan DCI, Wilson C, Harris AL. Amino acid sensing by mTORC1: intracellular transporters mark the spot. Cell Metab. 2016;23:580\u20139.","journal-title":"Cell Metab"},{"key":"164_CR17","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.pharmthera.2008.09.005","volume":"121","author":"V Ganapathy","year":"2009","unstructured":"Ganapathy V, Thangaraju M, Prasad PD. Nutrient transporters in cancer: relevance to Warburg effect and beyond. Pharmacol Ther. 2009;121:29\u201340.","journal-title":"Pharmacol Ther"},{"key":"164_CR18","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1158\/0008-5472.CAN-14-3745","volume":"75","author":"YD Bhutia","year":"2015","unstructured":"Bhutia YD, Babu E, Ramachandran S, Ganapathy V. Amino acid transporters in cancer and their relevance to \u201cglutamine addiction\u201d: novel targets for the design of a new class of anticancer drugs. Cancer Res. 2015;75:1782\u20138.","journal-title":"Cancer Res"},{"key":"164_CR19","first-page":"1281","volume":"5","author":"Q Wang","year":"2015","unstructured":"Wang Q, Holst J. L-type amino acid transport and cancer: targeting the mTORC1 pathway to inhibit neoplasia. Am J Cancer Res. 2015;5:1281\u201394.","journal-title":"Am J Cancer Res"},{"key":"164_CR20","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.molcel.2012.09.017","volume":"48","author":"A Elorza","year":"2012","unstructured":"Elorza A, Soro-Arnaiz I, Melendez-Rodriguez F, Rodriguez-Vaello V, Marsboom G, de Carcer G, et al. HIF2\u03b1 acts as an mTORC1 activator through the amino acid carrier SLC7A5. Mol Cell. 2012;48:681\u201391.","journal-title":"Mol Cell"},{"key":"164_CR21","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1002\/jcp.21366","volume":"215","author":"M Lo","year":"2008","unstructured":"Lo M, Wang YZ, Gout PW. The xc- cystine\/glutamate antiporter: a potential target for therapy of cancer and other diseases. J Cell Physiol. 2008;215:593\u2013602.","journal-title":"J Cell Physiol"},{"key":"164_CR22","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1089\/ars.2011.4391","volume":"18","author":"J Lewerenz","year":"2013","unstructured":"Lewerenz J, Hewett SJ, Huang Y, Lambros M, Gout PW, Kalivas PW, et al. The cystine\/glutamate antiporter system xc- in health and disease: from molecular mechanisms to novel therapeutic opportunities. Antioxid Redox Signal. 2013;18:522\u201355.","journal-title":"Antioxid Redox Signal"},{"key":"164_CR23","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","volume":"49","author":"SJ Dixon","year":"2012","unstructured":"Dixon SJ, Lemberg KM, Lamprecht MR, Skouta R, Zaitsev EM, Gleason CE, et al. Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell. 2012;49:1060\u201372.","journal-title":"Cell"},{"key":"164_CR24","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nature14344","volume":"520","author":"L Jiang","year":"2015","unstructured":"Jiang L, Kon N, Li T, Wang SJ, Su T, Hibshoosh H, et al. Ferroptosis as a p53-mediated activity during tumor suppression. Nature. 2015;520:57\u201362.","journal-title":"Nature"},{"key":"164_CR25","first-page":"2555","volume":"22","author":"D Witte","year":"2002","unstructured":"Witte D, Ali N, Carlson N, Younes M. Overexpression of the neutral amino acid transporter ASCT2 in human colorectal adenocarcinoma. Anticancer Res. 2002;22:2555\u20137.","journal-title":"Anticancer Res"},{"key":"164_CR26","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1038\/bjc.2014.88","volume":"110","author":"K Shimizu","year":"2014","unstructured":"Shimizu K, Kaira K, Tomizawa Y, Sunaga N, Kawashima O, Oriuchi N, et al. ASC amino-acid transporter 2 (ASCT2) as a novel prognostic marker in non-small cell lung cancer. Br J Cancer. 2014;110:2030\u20139.","journal-title":"Br J Cancer"},{"key":"164_CR27","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1111\/his.12464","volume":"66","author":"K Kaira","year":"2015","unstructured":"Kaira K, Sunose Y, Arakawa K, Sunaga N, Shimizu K, Tominaga H, et al. Clinicopathological significance of ASC amino acid transporter-2 expression in pancreatic ductal carcinoma. Histopathology. 2015;66:234\u201343.","journal-title":"Histopathology"},{"key":"164_CR28","doi-asserted-by":"crossref","first-page":"e367","DOI":"10.1038\/oncsis.2017.70","volume":"6","author":"AD Marshall","year":"2017","unstructured":"Marshall AD, van Geldermalsen M, Otte NJ, Lum T, Vellozi M, Thoeng A, et al. ASCT2 regulates glutamine uptake and cell growth in endometrial carcinoma. Oncogene. 2017;6:e367.","journal-title":"Oncogene"},{"key":"164_CR29","doi-asserted-by":"crossref","first-page":"3201","DOI":"10.1038\/onc.2015.381","volume":"35","author":"M Geldermalsen van","year":"2016","unstructured":"van Geldermalsen M, Wang Q, Nagarajah R, Marshall AD, Thoeng A, Gao D, et al. ASCT2\/SLC1A5 controls glutamine uptake and tumour growth in triple-negative basal-like breast cancer. Oncogene. 2016;35:3201\u20138.","journal-title":"Oncogene"},{"key":"164_CR30","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.cell.2008.11.044","volume":"136","author":"P Nicklin","year":"2009","unstructured":"Nicklin P, Bergman P, Zhang B, Triantafellow E, Wang H, Nyfeler B, et al. Bidirectional transport of amino acids regulates mTOR and autophagy. Cell. 2009;136:521\u201334.","journal-title":"Cell"},{"key":"164_CR31","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.bbadis.2005.04.002","volume":"1741","author":"N Gupta","year":"2005","unstructured":"Gupta N, Miyauchi S, Martindale RG, Herdman AV, Podolsky R, Miyake K, et al. Upregulation of the amino acid transporter ATB0,+ (SLC6A14) in colorectal cancer and metastasis in humans. Biochim Biophys Acta. 2005;1741:215\u201323.","journal-title":"Biochim Biophys Acta"},{"key":"164_CR32","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ygyno.2005.08.016","volume":"100","author":"N Gupta","year":"2006","unstructured":"Gupta N, Prasad PD, Ghamande S, Martin PM, Herdman AV, Martindale RG, et al. Up-regulation of the amino acid transporter ATB0,+ (SLC6A14) in carcinoma of the cervix. Gynecol Oncol. 2006;100:8\u201313.","journal-title":"Gynecol Oncol"},{"key":"164_CR33","doi-asserted-by":"crossref","first-page":"31830","DOI":"10.1074\/jbc.M111.229518","volume":"286","author":"S Karunakaran","year":"2011","unstructured":"Karunakaran S, Ramachandran S, Coothankandaswamy V, Elangovan S, Babu E, Periyasamy-Thandavan S, et al. SLC6A14 (ATB0,+) protein, a highly concentrative and broad specific amino acid transporter, is a novel and effective drug target for treatment of estrogen receptor-positive breast cancer. J Biol Chem. 2011;286:31830\u20138.","journal-title":"J Biol Chem"},{"key":"164_CR34","doi-asserted-by":"crossref","first-page":"593572","DOI":"10.1155\/2015\/593572","volume":"2015","author":"AR Penheiter","year":"2015","unstructured":"Penheiter AR, Erdogan S, Murphy SJ, Hart SN, Felipe LJ, Rohakhtar FR, et al. Transcriptomic and immunohistochemical profiling of SLC6A14 in pancreatic ductal adenocarcinoma. Biomed Res Int. 2015;2015:593572.","journal-title":"Biomed Res Int"},{"key":"164_CR35","doi-asserted-by":"crossref","first-page":"3292","DOI":"10.1111\/bph.13616","volume":"173","author":"V Coothankandaswamy","year":"2016","unstructured":"Coothankandaswamy V, Cao S, Xu Y, Prasad PD, Singh PK, Reynolds CP, et al. The amino acid transporter SLC6A14 is a novel and effective drug target for treatment of pancreatic cancer. Br J Pharmacol. 2016;173:3292\u2013306.","journal-title":"Br J Pharmacol"},{"key":"164_CR36","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1042\/BJ20080622","volume":"414","author":"S Karunakaran","year":"2008","unstructured":"Karunakaran S, Umapathy NS, Thangaraju M, Hatanaka T, Itagaki S, Munn DH, et al. Interaction of tryptophan derivatives with SLC6A14 (ATB0,+) reveals the potential of the transporter as a drug target for cancer chemotherapy. Biochem J. 2008;414:343\u201355.","journal-title":"Biochem J"},{"key":"164_CR37","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1042\/BJ20150437","volume":"469","author":"E Babu","year":"2015","unstructured":"Babu E, Bhutia YD, Ramachandran S, Gnanaprakasam JP, Prasad PD, Thangaraju M, et al. Deletion of the amino acid transporter Slc6a14 suppresses tumour growth in spontaneous mouse models of breast cancer. Biochem J. 2015;469:17\u201323.","journal-title":"Biochem J"},{"key":"164_CR38","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1517\/14712598.7.9.1375","volume":"7","author":"A Giannakakis","year":"2007","unstructured":"Giannakakis A, Coukos G, Hatzigeorgiou A, Sandaltzopoulos R, Zhang L. miRNA genetic alterations in human cancers. Expert Opin Biol Ther. 2007;7:1375\u201386.","journal-title":"Expert Opin Biol Ther"},{"key":"164_CR39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ydbio.2006.08.028","volume":"302","author":"B Zhang","year":"2007","unstructured":"Zhang B, Pan X, Cobb GP, Anderson TA. microRNAs as oncogenes and tumor suppressors. Dev Biol. 2007;302:1\u201312.","journal-title":"Dev Biol"},{"key":"164_CR40","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.semcancer.2008.01.008","volume":"18","author":"AL Gartel","year":"2008","unstructured":"Gartel AL, Kandel ES. miRNAs: little known mediators of oncogenesis. Semin Cancer Biol. 2008;18:103\u201310.","journal-title":"Semin Cancer Biol"},{"key":"164_CR41","doi-asserted-by":"crossref","first-page":"27","DOI":"10.3892\/etm.2010.164","volume":"2","author":"M Zhu","year":"2011","unstructured":"Zhu M, Wang N, Tsao SW, Yuen MF, Feng Y, Wan TS, et al. Up-regulation of microRNAs, miR21 and miR23a, in human liver cancer cells treated with Coptidis rhizome aqueous extract. Exp Ther Med. 2011;2:27\u201332.","journal-title":"Exp Ther Med"},{"key":"164_CR42","doi-asserted-by":"crossref","first-page":"e87767","DOI":"10.1371\/journal.pone.0087767","volume":"9","author":"XH Li","year":"2014","unstructured":"Li XH, Qu JQ, Yi H, Zhang PF, Yi HM, Wan XX, et al. Integrated analysis of differential miRNA and mRNA expression profiles in human radioresistant and radiosensitive nasopharyngeal carcinoma cells. PLoS One. 2014;9:e87767.","journal-title":"PLoS One"},{"key":"164_CR43","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1038\/nature07823","volume":"458","author":"P Gao","year":"2009","unstructured":"Gao P, Tchernyshyov I, Chang TC, Lee YS, Kita K, Ochi T, et al. c-Myc suppression of miR-23a\/b enhances mitochondrial glutaminase expression and glutamine metabolism. Nature. 2009;458:762\u20135.","journal-title":"Nature"},{"key":"164_CR44","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1016\/j.cell.2016.11.013","volume":"167","author":"DC Tarlungeanu","year":"2016","unstructured":"Tarlungeanu DC, Deliu E, Dotter CP, Kara M, Janiesch PC, Scalise M, et al. Impaired amino acid transport at the blood brain barrier is a cause of autism spectrum disorder. Cell. 2016;167:1481\u201394.","journal-title":"Cell"},{"key":"164_CR45","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/S0720-048X(00)00238-2","volume":"35","author":"K Karlinger","year":"2000","unstructured":"Karlinger K, Gyorke T, Mako E, Mester A, Tarjan Z. The epidemiology and the pathogenesis of inflammatory bowel disease. Eur J Radiol. 2000;35:154\u201367.","journal-title":"Eur J Radiol"},{"key":"164_CR46","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/nrgastro.2015.186","volume":"13","author":"HS Souza de","year":"2016","unstructured":"de Souza HS, Fiocchi C. Immunopathogenesis of IBD: current state of the art. Nat Rev Gastroenterol Hepatol. 2016;13:13\u201327.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"164_CR47","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1097\/01.mib.0000232469.23574.11","volume":"12","author":"CF Flach","year":"2006","unstructured":"Flach CF, Eriksson A, Jennische E, Lange S, Gunnerek C, Lonnroth I. Detection of elafin as a candidate biomarker for ulcerative colitis by whole-genome microarray screening. Inflamm Bowel Dis. 2006;12:837\u201342.","journal-title":"Inflamm Bowel Dis"},{"key":"164_CR48","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/1471-230X-8-34","volume":"8","author":"A Eriksson","year":"2008","unstructured":"Eriksson A, Flach CF, Lindgren A, Kvifors E, Lange S. Five mucosal transcripts of interest in ulcerative colitis identified by quantitative real-time PCR: a prospective study. BMC Gastroenterol. 2008;8:34.","journal-title":"BMC Gastroenterol"},{"key":"164_CR49","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1136\/gutjnl-2014-307387","volume":"64","author":"H Yanai","year":"2015","unstructured":"Yanai H, Ben-Shachar S, Baram L, Elad H, Gitstein G, Brazowski E, et al. Gene expression alterations in ulcerative colitis patients after restorative proctocolectomy extand to the small bowel proximal to the pouch. Gut. 2015;64:756\u201364.","journal-title":"Gut"},{"key":"164_CR50","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1097\/MEG.0b013e3282f3557c","volume":"20","author":"A Eriksson","year":"2008","unstructured":"Eriksson A, Jennische E, Flach CF, Jorge A, Lange S. Real-time PCR amplification analysis of five mucosal transcripts in patients with Crohn\u2019s disease. Eur J Gastroenterol Hepatol. 2008;20:290\u20136.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"164_CR51","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1007\/s00726-014-1773-4","volume":"47","author":"B Wang","year":"2015","unstructured":"Wang B, Wu G, Zhou Z, Dai Z, Sun Y, Ji Y, et al. Glutamine and intestinal barrier function. Amino Acids. 2015;47:2143\u201354.","journal-title":"Amino Acids"},{"key":"164_CR52","doi-asserted-by":"crossref","first-page":"62","DOI":"10.3389\/fcell.2015.00062","volume":"3","author":"EA Novak","year":"2015","unstructured":"Novak EA, Mollen KP. Mitochondrial dysfunction in inflammatory bowel disease. Front Cell Dev Biol. 2015;3:62.","journal-title":"Front Cell Dev Biol"},{"key":"164_CR53","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1097\/00054725-200305000-00006","volume":"9","author":"RK Cross","year":"2003","unstructured":"Cross RK, Wilson KT. Nitric oxide in inflammatory bowel disease. Inflamm Bowel Dis. 2003;9:179\u201389.","journal-title":"Inflamm Bowel Dis"},{"key":"164_CR54","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1111\/j.1365-2567.2004.01984.x","volume":"113","author":"G Kolios","year":"2004","unstructured":"Kolios G, Valatas V, Ward SG. Nitric oxide in inflammatory bowel disease: a universal messenger in an unsolved puzzle. Immunology. 2004;113:427\u201337.","journal-title":"Immunology"},{"key":"164_CR55","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1172\/JCI200317491","volume":"112","author":"E Suviolahti","year":"2003","unstructured":"Suviolahti E, Oksanen LJ, Ohman M, Cantor RM, Ridderstrale M, Tuomi T, et al. The SLC6A14 gene shows evidence of association with obesity. J Clin Invest. 2003;112:1762\u201372.","journal-title":"J Clin Invest"},{"key":"164_CR56","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.2337\/diabetes.53.9.2483","volume":"53","author":"E Durand","year":"2004","unstructured":"Durand E, Boutin P, Meyre D, Charles MA, Clement K, Dina C, et al. Polymorphisms in the amino acid transporter solute carrier family 6 (neurotransmitter transporter) member 14 gene contribute to polygenic obesity in French Caucasians. Diabetes. 2004;53:2483\u20136.","journal-title":"Diabetes"},{"key":"164_CR57","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1038\/oby.2009.377","volume":"18","author":"E Corpeleijn","year":"2010","unstructured":"Corpeleijn E, Petersen L, Holst C, Saris WH, Astrup A, Langin D, et al. Obesity-related polymorphisms and their associations with the ability to regulate fat oxidation in obese Europeans: the NUGENOB study. Obesity. 2010;18:1369\u201377.","journal-title":"Obesity"},{"key":"164_CR58","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1016\/j.clinbiochem.2015.07.003","volume":"48","author":"RC Miranda","year":"2015","unstructured":"Miranda RC, Vetter SB, Genro JP, Campagnolo PD, Mattevi VS, Vitolo MR, et al. SLC6A14 and 5-HTR2C polymorphisms are associated with food intake and nutritional status in children. Clin Biochem. 2015;48:1277\u201382.","journal-title":"Clin Biochem"},{"key":"164_CR59","first-page":"183","volume":"85","author":"M Ohman","year":"2000","unstructured":"Ohman M, Oksanen L, Kaprio J, Koskenvuo M, Mustajoki P, Rissanen A, et al. Genome-wide scan of obesity in Finnish sibpairs reveals linkage to chromosome Xq24. J Clin Endocrinol Metab. 2000;85:183\u201390.","journal-title":"J Clin Endocrinol Metab"},{"key":"164_CR60","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1038\/3123","volume":"20","author":"J Hager","year":"1998","unstructured":"Hager J, Dina C, Francke S, Dubois S, Houari M, Vatin V, et al. A genome-wide scan for human obesity genes reveals a major susceptibility on chromosome 10. Nat Genet. 1998;20:304\u20138.","journal-title":"Nat Genet"},{"key":"164_CR61","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1086\/340670","volume":"70","author":"S Stone","year":"2002","unstructured":"Stone S, Abkevich V, Hunt SC, Gutin A, Russell DL, Neff CD, et al. A major predisposition locus for severe obesity at 4p15-p14. Am J Hum Genet. 2002;70:1459\u201368.","journal-title":"Am J Hum Genet"},{"key":"164_CR62","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1172\/JCI200320448","volume":"112","author":"HK Tiwari","year":"2003","unstructured":"Tiwari HK, Allison DB. Do allelic variants of SLC6A14 predispose to obesity? J Clin Invest. 2003;112:1633\u20136.","journal-title":"J Clin Invest"},{"key":"164_CR63","doi-asserted-by":"crossref","first-page":"23740","DOI":"10.1074\/jbc.274.34.23740","volume":"274","author":"JL Sloan","year":"1999","unstructured":"Sloan JL, Mager S. Cloning and functional expression of a human Na+ and Cl--dependent neutral and cationic amino acid transporter B0,+. J Biol Chem. 1999;274:23740\u20135.","journal-title":"J Biol Chem"},{"key":"164_CR64","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1172\/JCI107335","volume":"52","author":"SA Adibi","year":"1973","unstructured":"Adibi SA, Mercer DW. Protein digestion in human intestine as reflected in luminal, mucosal, and plasma amino acid concentrations after meals. J Clin Invest. 1973;52:1586\u201394.","journal-title":"J Clin Invest"},{"key":"164_CR65","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s00439-013-1363-7","volume":"133","author":"W Li","year":"2014","unstructured":"Li W, Soave D, Miller MR, Keenan K, Lin F, Gong J, et al. Unraveling the complex genetic model for cystic fibrosis: pleiotropic effects of modifier genes on early cystic fibrosis-related morbidities. Hum Genet. 2014;133:151\u201361.","journal-title":"Hum Genet"},{"key":"164_CR66","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1038\/ng.2221","volume":"44","author":"L Sun","year":"2012","unstructured":"Sun L, Rommens JM, Corvol H, Li W, Li X, Chiang TA, et al. Multiple apical plasma membrane constituents are associated with susceptibility to meconium ileus in individuals with cystic fibrosis. Nat Genet. 2012;44:562\u20139.","journal-title":"Nat Genet"},{"key":"164_CR67","doi-asserted-by":"crossref","first-page":"8382","DOI":"10.1038\/ncomms9382","volume":"6","author":"H Corvol","year":"2015","unstructured":"Corvol H, Blackman SM, Boelle PY, Gallins PJ, Pace RG, Stonebraker JR, et al. Genome-wide association meta-analysis identifies five modifier loci of lung disease severity in cystic fibrosis. Nat Commun. 2015;6:8382.","journal-title":"Nat Commun"},{"key":"164_CR68","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.gene.2017.07.068","volume":"629","author":"SV Pereira","year":"2017","unstructured":"Pereira SV, Ribeiro JD, Bertuzzo CS, Marson FAL. Association of clinical severity of cystic fibrosis with variants in the SLC gene family (SLC6A14, SLC26A9, SLC11A1, and SLC9A3). Gene. 2017;629:117\u201326.","journal-title":"Gene"},{"key":"164_CR69","first-page":"145","volume":"61","author":"E Siasi","year":"2016","unstructured":"Siasi E, Aleyasin A. Four single nucleotide polymorphisms in INSR, SLC6A14, TAS2R38, and OR2W3 genes in association with idiopathic infertility in Persian men. J Reprod Med. 2016;61:145\u201352.","journal-title":"J Reprod Med"},{"key":"164_CR70","doi-asserted-by":"crossref","first-page":"61","DOI":"10.2478\/bjmg-2014-0075","volume":"17","author":"P Noveski","year":"2014","unstructured":"Noveski P, Mircevska M, Plaseski T, Peterlin B, Plaseska-Karanfilska D. Study of three single nucleotide polymorphisms in the SLC6A14 gene in association with male infertility. Balkan J Med Genet. 2014;17:61\u20136.","journal-title":"Balkan J Med Genet"},{"key":"164_CR71","doi-asserted-by":"crossref","first-page":"3026","DOI":"10.1210\/endo.133.6.8243331","volume":"133","author":"JC Tinajero","year":"1993","unstructured":"Tinajero JC, Fabbri A, Ciocca DR, Dufau ML. Serotonin secretion from rat Leydig cells. Endocrinology. 1993;133:3026\u20139.","journal-title":"Endocrinology"},{"key":"164_CR72","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1530\/rep.1.00598","volume":"129","author":"MA Aragon","year":"2005","unstructured":"Aragon MA, Ayala ME, Marin M, Aviles A, Damian-Matsumura P, Dominguez R. Serotonergic system blockage in the prepubertal rat inhibits spermatogenesis development. Reproduction. 2005;129:717\u201327.","journal-title":"Reproduction"},{"key":"164_CR73","doi-asserted-by":"crossref","first-page":"357","DOI":"10.2174\/156800805774912953","volume":"5","author":"ME Ganapathy","year":"2005","unstructured":"Ganapathy ME, Ganapathy V. Amino acid transporter ATB0,+ as a delivery system for drugs and prodrugs. Curr Drug Targets Immune Endocr Metabol Disord. 2005;5:357\u201364.","journal-title":"Curr Drug Targets Immune Endocr Metabol Disord"},{"key":"164_CR74","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.ajps.2014.04.004","volume":"9","author":"YD Bhutia","year":"2014","unstructured":"Bhutia YD, Babu E, Prasad PD, Ganapathy V. The amino acid transporter SLC6A14 in cancer and its potential use in chemotherapy. Asian J Pharm Sci. 2014;9:293\u2013303.","journal-title":"Asian J Pharm Sci"},{"key":"164_CR75","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1124\/jpet.103.057109","volume":"308","author":"T Hatanaka","year":"2004","unstructured":"Hatanaka T, Haramura M, Fei YJ, Miyauchi S, Bridges CC, Ganapathy PS, et al. Transport of amino acid-based prodrugs by the Na+- and Cl--coupled amino acid transporter ATB0,+ and expression of the transporter in tissues amenable for drug delivery. J Pharmacol Exp Ther. 2004;308:1138\u201347.","journal-title":"J Pharmacol Exp Ther"},{"key":"164_CR76","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1023\/B:PHAM.0000033019.49737.28","volume":"21","author":"NS Umapathy","year":"2004","unstructured":"Umapathy NS, Ganapathy V, Ganapathy ME. Transport of amino acid esters and the amino-acid-based prodrug valganciclovir by the amino acid transporter ATB0,+. Pharm Res. 2004;21:1303\u201310.","journal-title":"Pharm Res"},{"key":"164_CR77","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1080\/00365520902745039","volume":"44","author":"R Andersson","year":"2009","unstructured":"Andersson R, Aho U, Nilsson BI, Peters GJ, Pastor-Anglada M, Rasch W, et al. Gemcitabine chemoresistance in pancreatic cancer: molecular mechanisms and potential solutions. Scand J Gastroenterol. 2009;44:782\u20136.","journal-title":"Scand J Gastroenterol"},{"key":"164_CR78","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1158\/0008-5472.CAN-10-2736","volume":"71","author":"YD Bhutia","year":"2011","unstructured":"Bhutia YD, Hung SW, Patel B, Lovin D, Govindarajan R. CNT1 expression influences proliferation and chemosensitivity in drug-resistant pancreatic cancer cells. Cancer Res. 2011;71:1825\u201335.","journal-title":"Cancer Res"},{"key":"164_CR79","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1172\/JCI12060","volume":"107","author":"T Hatanaka","year":"2001","unstructured":"Hatanaka T, Nakanishi T, Huang W, Leibach FH, Prasad PD, Ganapathy V, et al. Na+- and Cl--coupled active transport of nitric oxide synthase inhibitors via amino acid transport system B0,+. J Clin Invest. 2001;107:1035\u201343.","journal-title":"J Clin Invest"},{"key":"164_CR80","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/j.1469-7793.2001.0297f.x","volume":"532","author":"T Nakanishi","year":"2001","unstructured":"Nakanishi T, Hatanaka T, Huang W, Prasad PD, Leibach FH, Ganapathy ME, et al. Na+- and Cl--coupled active transport of carnitine by the amino acid transporter ATB0,+ from mouse colon expressed in HRPE cells and Xenopus oocytes. J Physiol. 2001;532:297\u2013304.","journal-title":"J Physiol"},{"key":"164_CR81","doi-asserted-by":"crossref","first-page":"G1046","DOI":"10.1152\/ajpgi.00233.2007","volume":"293","author":"SR Srinivas","year":"2007","unstructured":"Srinivas SR, Prasad PD, Umapathy NS, Ganapathy V, Shekhawat PS. Transport of butyryl-L-carnitine, a potential prodrug, via the carnitine transporter OCTN2 and the amino acid transporter ATB0,+. Am J Physiol Gastrointest Liver Physiol. 2007;293:G1046\u201353.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"164_CR82","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.colsurfb.2016.01.041","volume":"141","author":"L Li","year":"2016","unstructured":"Li L, Di X, Zhang S, Kan Q, Liu H, Lu T, et al. Large amino acid transporter 1 mediated glutamate modified docetaxel-loaded liposomes for glioma targeting. Colloids Surf B Biointerfaces. 2016;141:260\u20137.","journal-title":"Colloids Surf B Biointerfaces"},{"key":"164_CR83","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.biomaterials.2013.09.094","volume":"35","author":"X Jiang","year":"2014","unstructured":"Jiang X, Xin H, Ren Q, Gu J, Zhu L, Du F, et al. Nanoparticles of 2-deoxy-D-glucose functionalized poly(ethylene glycol)-co-poly(trimethylene carbonate) for dual-targeted drug delivery in glioma treatment. Biomaterials. 2014;35:518\u201329.","journal-title":"Biomaterials"},{"key":"164_CR84","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.1021\/bc900369d","volume":"20","author":"S Salmaso","year":"2009","unstructured":"Salmaso S, Pappalardo JS, Sawant RR, Musacchio T, Rockwell K, Caliceti P, et al. Targeting glioma cells in vitro with ascorbate-conjugated pharmaceutical nanocarriers. Bioconjug Chem. 2009;20:2348\u201355.","journal-title":"Bioconjug Chem"},{"key":"164_CR85","doi-asserted-by":"publisher","unstructured":"Kou L, Yao Q, Sun M, Wu C, Wang J, Luo Q, et al. Cotransporting ion is a trigger for cellular endocytosis of transporter-targeting nanoparticles: a case study of high-efficiency SLC22A5 (OCTN2)-mediated carnitine-conjugated nanoparticles for oral delivery of therapeutic drugs. Adv healthc Mater. 2017; https:\/\/doi.org\/10.1002\/adhm.201700165 .","DOI":"10.1002\/adhm.201700165"},{"key":"164_CR86","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.jconrel.2016.10.031","volume":"243","author":"Q Luo","year":"2016","unstructured":"Luo Q, Gong P, Sun M, Kou L, Ganapathy V, Jing Y, et al. Transporter-occluded-state conformation-induced endocytosis: amino acid transporter ATB0,+-mediated tumor targeting of liposomes for docetaxel delivery for hepatocarcinoma therapy. J Control Release. 2016;243:370\u201380.","journal-title":"J Control Release"},{"key":"164_CR87","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1667\/RR2702.1","volume":"177","author":"A Zhu","year":"2012","unstructured":"Zhu A, Marcus DM, Shu HK, Shim H. Application of metabolic PET imaging in radiation oncology. Radiat Res. 2012;177:436\u201348.","journal-title":"Radiat Res"},{"key":"164_CR88","doi-asserted-by":"crossref","first-page":"E4111","DOI":"10.1073\/pnas.1511698112","volume":"112","author":"C Scafoglio","year":"2015","unstructured":"Scafoglio C, Hirayama BA, Kepe V, Liu J, Ghezzi C, Satyamurthy N, et al. Functional expression of sodium-glucose transporters in cancer. Proc Natl Acad Sci U S A. 2015;112:E4111\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"164_CR89","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/s11307-013-0711-2","volume":"16","author":"A Muller","year":"2014","unstructured":"Muller A, Chiotellis A, Keller C, Ametamey SM, Schibli R, Mu L, et al. Imaging tumour ATB0,+ transport activity by PET with the cationic amino acid O-2((2-[18F]fluoroethyl)methylamino)ethyltyrosine. Mol Imaging Biol. 2014;16:412\u201320.","journal-title":"Mol Imaging Biol"},{"key":"164_CR90","doi-asserted-by":"crossref","unstructured":"Chiotellis A, Muller A, Weyermann K, Leutwiler DS, Schibli R, Ametamey SM, et al. Synthesis and preliminary biological evaluation of O-2((2-[18F]fluoroethyl)methylamino)ethyltyrosine ([(18F]FEMAET) as a potential cationic amino acid PET tracer for tumor imaging. Amino Acids 2014;46:1947\u201359.","DOI":"10.1007\/s00726-014-1754-7"},{"key":"164_CR91","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1111\/cas.12602","volume":"106","author":"P Wongthai","year":"2015","unstructured":"Wongthai P, Hagiwara K, Miyoshi Y, Wiriyasermkul P, Wei L, Ohgaki R, et al. Boronophenylalanine, a boron delivery agents for boron neutron capture therapy, is transported by ATB0,+, LAT1 and LAT2. Cancer Sci. 2015;106:279\u201386.","journal-title":"Cancer Sci"}],"container-title":["The AAPS Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1208\/s12248-017-0164-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1208\/s12248-017-0164-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1208\/s12248-017-0164-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,9]],"date-time":"2022-08-09T21:46:08Z","timestamp":1660081568000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1208\/s12248-017-0164-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12,4]]},"references-count":91,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,1]]}},"alternative-id":["164"],"URL":"https:\/\/doi.org\/10.1208\/s12248-017-0164-7","relation":{},"ISSN":["1550-7416"],"issn-type":[{"value":"1550-7416","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12,4]]},"article-number":"12"}}